Allison Hagerman, CTO of Oncolytics Biotech ONCY, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $8,300. The latest trade was on 06/01.

AH

AH

Allison Hagerman

CTO

Company

Oncolytics Biotech ONCY

First filing

26/02/13

Trades

2 trades

Buys / sales

1 / 0

12-month net buying

$8,300

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Oncolytics BiotechONCY	Open-market buy	02/12	02/13	10,000 sh	$0.83	$8,300	+9.5%